Takeda Pharmaceutical Company Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
18.13
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
0.15
|
0.00
|
-0.15
|
-100.00%
|
|
2022-12-31
|
0.25
|
0.00
|
-0.25
|
-100.00%
|
|
2022-09-30
|
0.18
|
0.13
|
-0.04
|
-23.45%
|
|
2022-06-30
|
0.24
|
0.25
|
0.02
|
7.03%
|
|
2022-03-31
|
0.06
|
-0.03
|
-0.09
|
-144.72%
|
|
2021-12-31
|
0.22
|
0.16
|
-0.06
|
-27.21%
|
|
2021-09-30
|
0.23
|
-0.05
|
-0.28
|
-120.52%
|
|
2021-06-30
|
0.33
|
0.59
|
0.26
|
77.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.39
|
|
2022-03-31
|
0.67
|
|
2021-03-31
|
28.54
|
|
2020-03-31
|
3.65
|
|
2019-03-31
|
0.32
|
|
2018-03-31
|
1.08
|
|
2017-03-31
|
0.69
|
|
2016-03-31
|
0.41
|
|
2015-03-31
|
-0.72
|
|
2014-03-31
|
0.58
|
|
2013-03-31
|
1.05
|
|
2012-03-31
|
0.99
|
|
2011-03-31
|
1.85
|
|
2009-03-31
|
0.85
|
|
2008-03-31
|
0.14
|